Prostate cancer affects one in six men and is the second leading cause of cancer death in men in the United States. In this episode, Hyung Kim, MD, chief of urological oncology, discusses treatments and technologies that have improved the ability to diagnose and treat prostate cancer. In particular, he shares how HIFU – high-intensity focused ultrasound – has revolutionized the management of prostate cancer, his contributions to kidney cancer research and his work with tumor immunology.
For Healthcare Professionals: To claim CME credit for this activity, please click here to be redirected to the Cedars-Sinai CME Portal.
Created by
Related Presenters
Co-Medical Director, Urologic Oncology Center
Director, Academic Urology Program
Hyung L. Kim, MD, is director of the Cedars-Sinai Academic Urology Program and associate director of Surgical Research in the Samuel Oschin Comprehensive Cancer Center. He has two professional passions. As a practicing urologic oncologist, ...
Surgeon-In-Chief
Vice Dean, Avademic Affairs
The research of Bruce L. Gewertz, MD, focuses on human factors in delivery of health care and the distribution of surgical service. His clinical interests include cerebrovascular disease, especially intraoperative neurophysiologic monitoring ...
BROADCASTMED